Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults

This study is currently recruiting participants.
Verified March 2014 by University of Cincinnati
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by (Responsible Party):
Melissa Delbello, University of Cincinnati
ClinicalTrials.gov Identifier:
NCT00845507
First received: February 16, 2009
Last updated: March 13, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)